Dr Ammar Y Ali, MD | |
22301 Foster Winter Dr, 2nd Floor, Southfield, MI 48075-3707 | |
(248) 552-0620 | |
Not Available |
Full Name | Dr Ammar Y Ali |
---|---|
Gender | Male |
Speciality | Infectious Disease |
Experience | 28 Years |
Location | 22301 Foster Winter Dr, Southfield, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558572677 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | 4301074913 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ascension Providence Hospital, Southfield And Novi | Southfield, MI | Hospital |
Ascension St John Hospital | Detroit, MI | Hospital |
Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ascension St John Hospital | 3173424082 | 296 |
News Archive
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the first patient has been treated in its clinical trial of STA-9090 in combination with docetaxel for the treatment of advanced solid tumor malignancies.
Vermillion, Inc., a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012.
Syntiron today announced that it has granted sanofi pasteur an exclusive world-wide license to its human vaccine against Staphylococcus aureus. The agreement includes an undisclosed initial licensing fee, milestone payments and royalty payments on future sales of the product. Staphylococcus aureus, or MRSA (pronounced Mer-sa) is an important hospital-acquired infection and is a major cause of illness and death resulting in excess of 18,000 US deaths a year and a half million hospitalizations, creating a significant economic burden of approximately $3.4 billion annually to the American health care system.
A latest report by the World Economic Forum (WEF) suggests that the global economic impact of the five leading chronic diseases - cancer, diabetes, mental illness, heart disease, and respiratory disease - could reach $47 trillion over the next 20 years.
› Verified 2 days ago
Entity Name | Ascension St John Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043478910 PECOS PAC ID: 3173424082 Enrollment ID: O20040115000409 |
News Archive
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the first patient has been treated in its clinical trial of STA-9090 in combination with docetaxel for the treatment of advanced solid tumor malignancies.
Vermillion, Inc., a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012.
Syntiron today announced that it has granted sanofi pasteur an exclusive world-wide license to its human vaccine against Staphylococcus aureus. The agreement includes an undisclosed initial licensing fee, milestone payments and royalty payments on future sales of the product. Staphylococcus aureus, or MRSA (pronounced Mer-sa) is an important hospital-acquired infection and is a major cause of illness and death resulting in excess of 18,000 US deaths a year and a half million hospitalizations, creating a significant economic burden of approximately $3.4 billion annually to the American health care system.
A latest report by the World Economic Forum (WEF) suggests that the global economic impact of the five leading chronic diseases - cancer, diabetes, mental illness, heart disease, and respiratory disease - could reach $47 trillion over the next 20 years.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Ammar Y Ali, MD 22301 Foster Winter Dr, 2nd Floor, Southfield, MI 48075-3707 Ph: (248) 370-0876 | Dr Ammar Y Ali, MD 22301 Foster Winter Dr, 2nd Floor, Southfield, MI 48075-3707 Ph: (248) 552-0620 |
News Archive
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the first patient has been treated in its clinical trial of STA-9090 in combination with docetaxel for the treatment of advanced solid tumor malignancies.
Vermillion, Inc., a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012.
Syntiron today announced that it has granted sanofi pasteur an exclusive world-wide license to its human vaccine against Staphylococcus aureus. The agreement includes an undisclosed initial licensing fee, milestone payments and royalty payments on future sales of the product. Staphylococcus aureus, or MRSA (pronounced Mer-sa) is an important hospital-acquired infection and is a major cause of illness and death resulting in excess of 18,000 US deaths a year and a half million hospitalizations, creating a significant economic burden of approximately $3.4 billion annually to the American health care system.
A latest report by the World Economic Forum (WEF) suggests that the global economic impact of the five leading chronic diseases - cancer, diabetes, mental illness, heart disease, and respiratory disease - could reach $47 trillion over the next 20 years.
› Verified 2 days ago
Surinder Mendiratta, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 20905 Greenfield Rd, Suite 502, Southfield, MI 48075 Phone: 248-395-2888 Fax: 248-395-2891 | |
Dr. Freddy R Sosa, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 22250 Providence Dr, Suite 703, Southfield, MI 48075 Phone: 248-569-1770 Fax: 248-443-2439 | |
Kun Kil Yu, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 19189 W 10 Mile Rd, Ste 200, Southfield, MI 48075 Phone: 248-948-7985 Fax: 248-948-9031 | |
Dr. Vilma Drelichman, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 22301 Foster Winter Dr, 2nd Floor, Southfield, MI 48075 Phone: 248-552-0620 Fax: 248-552-0286 | |
Dr. Sumner Camisa, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 29829 Telegraph Road, #100, Southfield, MI 48034 Phone: 248-355-3033 Fax: 248-355-4936 | |
Talal Taher Khader, M.D Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 16001 W 9 Mile Rd, 4th Fl Fisher Ctr, Southfield, MI 48075 Phone: 248-849-8483 | |
Dr. Herman Kado, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 28625 Northwestern Hwy, Suite 150, Southfield, MI 48034 Phone: 248-587-2300 Fax: 248-945-0492 |